Active Not RecruitingNCT03349528
Probiotics to prevent relapse after bipolar depression
About this title
Probiotics to Prevent Relapse After Hospitalization for Bipolar Depression
Read the official source — NCT03349528Placebo comparisonAges 18–65United StatesBipolarity
Understand this study
Who could participate?
Listed age limits: 18 years to 65 years.
- Listed locations
- TowsonSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: December 11, 2018
- Recruitment status
- Active Not Recruiting
- Enrollment listed in the registry
- 80
- Sponsor
- Sheppard Pratt Health System
- Sponsor type
- Unknown or unclear
- Study type
- Biological
- Intervention type
- Biological
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United States
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT03349528
- Official title
Show the full official title
A Double-Blind Placebo-Controlled Trial of a Probiotic Supplement to Prevent Relapse and Improve the Clinical Course After Hospitalization for Bipolar Depression
Recruitment & locations
Not recruitingThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Towson
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Sheppard Pratt Health System.
Who can participate?
Listed age limits: 18 years to 65 years.
Is this study still recruiting?
The registry lists this study as active, but no longer recruiting.
